• Je něco špatně v tomto záznamu ?

Chemical and Biological Aspects of Montanine-Type Alkaloids Isolated from Plants of the Amaryllidaceae Family

D. Koutová, N. Maafi, R. Havelek, L. Opletal, G. Blunden, M. Řezáčová, L. Cahlíková

. 2020 ; 25 (10) : . [pub] 20200516

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012582

Grantová podpora
SVV UK 260 548; Progres/UK Q40-01 and Q42 Univerzita Karlova v Praze
CZ.02.1.01/0.0/0.0/18_069/0010046 European Union

Plants of the Amaryllidaceae family are promising therapeutic tools for human diseases and have been used as alternative medicines. The specific secondary metabolites of this plant family, called Amaryllidaceae alkaloids (AA), have attracted considerable attention due to their interesting pharmacological activities. One of them, galantamine, is already used in the therapy of Alzheimer's disease as a long acting, selective, reversible inhibitor of acetylcholinesterase. One group of AA is the montanine-type, such as montanine, pancracine and others, which share a 5,11-methanomorphanthridine core. So far, only 14 montanine-type alkaloids have been isolated. Compared with other structural-types of AA, montanine-type alkaloids are predominantly present in plants in low concentrations, but some of them display promising biological properties, especially in vitro cytotoxic activity against different cancerous cell lines. The present review aims to summarize comprehensively the research that has been published on the Amaryllidaceae alkaloids of montanine-type.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012582
003      
CZ-PrNML
005      
20210507103657.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules25102337 $2 doi
035    __
$a (PubMed)32429491
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Koutová, Darja $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Králové, Charles University, Šimkova 870, 500 03 Hradec Králové, Czech Republic
245    10
$a Chemical and Biological Aspects of Montanine-Type Alkaloids Isolated from Plants of the Amaryllidaceae Family / $c D. Koutová, N. Maafi, R. Havelek, L. Opletal, G. Blunden, M. Řezáčová, L. Cahlíková
520    9_
$a Plants of the Amaryllidaceae family are promising therapeutic tools for human diseases and have been used as alternative medicines. The specific secondary metabolites of this plant family, called Amaryllidaceae alkaloids (AA), have attracted considerable attention due to their interesting pharmacological activities. One of them, galantamine, is already used in the therapy of Alzheimer's disease as a long acting, selective, reversible inhibitor of acetylcholinesterase. One group of AA is the montanine-type, such as montanine, pancracine and others, which share a 5,11-methanomorphanthridine core. So far, only 14 montanine-type alkaloids have been isolated. Compared with other structural-types of AA, montanine-type alkaloids are predominantly present in plants in low concentrations, but some of them display promising biological properties, especially in vitro cytotoxic activity against different cancerous cell lines. The present review aims to summarize comprehensively the research that has been published on the Amaryllidaceae alkaloids of montanine-type.
650    _2
$a Amaryllidaceae $x chemie $x metabolismus $7 D000070378
650    _2
$a alkaloidy amarylkovitých $x chemie $x izolace a purifikace $x farmakologie $7 D047151
650    _2
$a antitumorózní látky fytogenní $x chemie $x izolace a purifikace $x farmakologie $7 D000972
650    _2
$a antiprotozoální látky $x chemie $x izolace a purifikace $x farmakologie $7 D000981
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a cholinesterasové inhibitory $x chemie $x izolace a purifikace $x farmakologie $7 D002800
650    _2
$a galantamin $x chemie $x izolace a purifikace $x farmakologie $7 D005702
650    _2
$a heterocyklické sloučeniny tetra- a více cyklické $x chemie $x izolace a purifikace $x farmakologie $7 D006576
650    _2
$a lidé $7 D006801
650    _2
$a inhibiční koncentrace 50 $7 D020128
650    _2
$a isochinoliny $x chemie $x izolace a purifikace $x farmakologie $7 D007546
650    _2
$a nootropní látky $x chemie $x izolace a purifikace $x farmakologie $7 D018697
650    _2
$a fenantridiny $x chemie $x izolace a purifikace $x farmakologie $7 D010617
650    _2
$a rostlinné extrakty $x chemie $7 D010936
650    _2
$a sekundární metabolismus $7 D064210
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Maafi, Negar $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
700    1_
$a Havelek, Radim $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Králové, Charles University, Šimkova 870, 500 03 Hradec Králové, Czech Republic
700    1_
$a Opletal, Lubomír $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
700    1_
$a Blunden, Gerald $u School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, Hampshire P01 2DT, UK
700    1_
$a Řezáčová, Martina $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Králové, Charles University, Šimkova 870, 500 03 Hradec Králové, Czech Republic
700    1_
$a Cahlíková, Lucie $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 25, č. 10 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32429491 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507103656 $b ABA008
999    __
$a ok $b bmc $g 1650863 $s 1132961
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 25 $c 10 $e 20200516 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
GRA    __
$a SVV UK 260 548; Progres/UK Q40-01 and Q42 $p Univerzita Karlova v Praze
GRA    __
$a CZ.02.1.01/0.0/0.0/18_069/0010046 $p European Union
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace